Entera Bio Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Entera Bio Ltd., a foreign private issuer, covers the month of March 2020. The report, dated March 26, 2020, consists solely of a press release issued on that date, which is attached as Exhibit 99.1 and incorporated by reference.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document serves as a vehicle to distribute a press release and does not contain a financial statement or quantitative financial data within the provided text.
Material Changes
The filing text does not provide a clear value regarding material changes versus the prior comparable period. No comparative financial data or operational metrics are included in the provided content.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. While the filing incorporates a press release, the specific content of that release is not included in the provided text.
Key Facts for Investor Verification
- The filing is a Form 6-K submitted on March 26, 2020, by Entera Bio Ltd.
- The report contains no standalone financial data; it references an attached press release (Exhibit 99.1) for details.
- Investors must review the attached press release to understand the specific announcement or event triggering this filing.
- The registrant files annual reports under Form 20-F.